Minimal sex-differential modulation of reactivity to pathogens and toll-like receptor ligands following infant Bacillus Calmette–Guérin Russia vaccination
Bacillus Calmette–Guérin (BCG), the only licensed vaccine against tuberculosis, has been shown to provide heterologous protection against unrelated pathogens and enhance antibody responses to several routine expanded program on immunization (EPI) vaccines. Understanding these heterologous effects is...
Autori principali: | Darboe, F, Adetifa, JU, Reynolds, J, Hossin, S, Plebanski, M, Netea, MG, Rowland-Jones, SL, Sutherland, JS, Flanagan, KL |
---|---|
Natura: | Journal article |
Pubblicazione: |
Frontiers Media
2017
|
Documenti analoghi
Documenti analoghi
-
Minimal Sex-Differential Modulation of Reactivity to Pathogens and Toll-Like Receptor Ligands following Infant Bacillus Calmette–Guérin Russia Vaccination
di: Fatoumatta Darboe, et al.
Pubblicazione: (2017-09-01) -
Reiter's syndrome postintravesical Bacillus Calmette–Guérin instillations
di: Ng, K.L., et al.
Pubblicazione: (2017) -
Bacillus Calmette–Guérin Immunotherapy for Cancer
di: Fabíola Cardillo, et al.
Pubblicazione: (2021-05-01) -
Bacillus Calmette–Guérin and Bladder Cancer
di: Azad H.A. Razack
Pubblicazione: (2007-10-01) -
Hepatitis in Disseminated Bacillus Calmette-Guérin Infection
di: Markus U Göttke, et al.
Pubblicazione: (2000-01-01)